LV Unloading Does not Reduce Infarct Size in Anterior MI: STEMI DTU Trial
Key Points: Even after timely reperfusion, heart failure (HF) complicates a high proportion of acute myocardial infarctions (MIs), with longitudinal outcomes worsening... Read more.
In-Hospital Dapagliflozin Does Not Reduce CV Death or Worsening HF in Two Months, but Meta-Analysis Signals Potential Early Benefit
Key Points: Dapagliflozin is a key component of GDMT for heart failure, but it is unknown whether inpatient initiation improves outcomes. The DAPA ACT HF-TIMI 68... Read more.
AI-Powered Virtual Assistant Boosts GDMT Optimization. ASSIST-HF SIRIO
Key Points: Optimization of GDMT is critical, particularly in the initial months after diagnosis of HFrEF. An AI-powered virtual assistant resulted in 100% of enrolled... Read more.
Altshock2: No Benefit to IABP in HF-Cardiogenic Shock
Key Points: Prior trials have demonstrated limited benefit to intra-aortic balloon pump (IABP) use in acute myocardial infarction-related cardiogenic shock, but... Read more.
No Benefit to Fluid Restriction in Chronic HF: FRESH UP
Key Points: While fluid restriction is a standard recommendation for patients with chronic heart failure (HF), there is limited evidence to support its use. The... Read more.
Mitral Annular Calcification Severity Predicts Outcomes in Severe Aortic Stenosis Patients Undergoing TAVR
Key Points: The presence of mitral annular calcification (MAC) in prior studies of transcatheter aortic valve replacement (TAVR) has been associated with poor outcomes,... Read more.
ATTR-Specific Medication and AVR Improve Survival in Patients with Aortic Stenosis and ATTR Cardiac Amyloidosis
Key Takeaways: In this international registry, 266 patients with dual pathology, aortic stenosis and cardiac amyloidosis were identified and matched. A control... Read more.
SUMMIT Subanalysis: Tirzepatide Reduces Symptom Burden in Patients with Obesity-Related HFpEF
Key Points Patients with heart failure with preserved ejection fraction (HFpEF) and obesity often have significant functional limitations. The SUMMIT trial demonstrated... Read more.
QFR Did Not Meet Non-inferiority to FFR: FAVOR III Europe Trial
The FAVOR III Europe study aimed to investigate whether a QFR-based diagnostic strategy yields a non-inferior 12-month clinical outcome compared with an FFR-based... Read more.
Orbital Atherectomy No Benefit Over Conventional Ballon Dilatation in Calcified Lesions: ECLIPSE Trial
The ECLIPSE trial evaluated orbital atherectomy (OA) vs conventional balloon dilatation (BA) in patients with de novo severely calcified lesions. The trial found... Read more.